Measles-Mumps-Rubella Vaccine
Research News and Information

Sunday, November 22, 2009

Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006.

29 Sep 2009 Following the clinical diagnosis of the first case of mumps on September 22, 2006 at the University of Virginia (UVA), 52 suspected cases were identified through active surveillance for mumps by the end of December 2006. Samples were collected from ... Read more...

Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine.

13 Sep 2009 BACKGROUND: Since 1990, most schoolchildren in the United States have received a second dose of measles-mumps-rubella vaccine (MMR2) at kindergarten entry. Elimination of endemic rubella virus circulation in the United States was declared in 2004. ... Read more...

Parental vaccine concerns in Kentucky.

30 Aug 2009 BACKGROUND: An increasing number of parents are questioning the safety and necessity of routine childhood immunizations. Locally produced vaccine risk communication materials may be effective in reassuring these parents. However, little is known ... Read more...

Latest indexed articles for 'Measles-Mumps-Rubella Vaccine'

These are the very latest articles for this heading:

• Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. 29 Sep 2009
• Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine. 13 Sep 2009
• Parental vaccine concerns in Kentucky. 30 Aug 2009
• Measles road show visits 12 hot spots in England. 4 Aug 2009
• A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk. 24 Jul 2009
• Safety of a refrigerator-stable varicella vaccine (VARIVAX) in healthy 12- to 15-month-old children: A randomized, double-blind, cross-over study. 21 Jul 2009
• Reducing immunization discomfort in 4- to 6-year-old children: a randomized clinical trial. 11 Jul 2009
• Impact of a measles elimination strategy on measles incidence in Malaysia. 29 Jun 2009
• Autism and vaccination-the current evidence. 29 Jun 2009
• Phenotypic expression of autoimmune autistic disorder (AAD): a major subset of autism. 29 Jun 2009
• Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine. 28 Jun 2009
• Vaccine disputes. 20 Jun 2009
• A new, rapid, and promising approach to aerosol immunization: inflatable bags and valved masks. 15 Jun 2009
• Litigation, regulation, and education--protecting the public's health through childhood immunization. 9 Jun 2009
• When vaccine injury claims go to court. 9 Jun 2009
• Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. 7 Jun 2009
• Measles outbreak in Wales will get worse, officials have warned. 7 Jun 2009
• Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium. 5 May 2009
• Immune response to measles vaccine after mass vaccination in Urmia, Islamic Republic of Iran. 29 Apr 2009
• Transparency, accountability and vaccination policy. 29 Apr 2009

See a longer list of these articles.

Technical information about 'Measles-Mumps-Rubella Vaccine'

Definition: A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.

Registry Number: 0

Descriptor UI: D022542

Alternative terms: Measles-Mumps-Rubella Vaccine; Measles Mumps Rubella Vaccine; Vaccine, Measles-Mumps-Rubella; MMR Vaccine; Vaccine, MMR; Mumps-Measles-Rubella Vaccine; Mumps Measles Rubella Vaccine; Vaccine, Mumps-Measles-Rubella; Measles, Mumps, Rubella Vaccine; Triviraten Berna; Berna, Triviraten; Priorix; Trimovax; Virivac; Pluserix;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D20.215.894.815.500; D20.215.894.899.390; D20.215.894.899.404.500; D20.215.894.899.488.500; D20.215.894.899.779.500;

History Note: 2001; use MEASLES-MUMPS-RUBELLA VACCINE (NM) to search MEASLES, MUMPS, RUBELLA VACCINE 1986-2000